Schedule 13G ownership disclosure
Eloxx Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 29014R103
Event date: 2017-12-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 2.5100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-17-065932
- Form type
- SC 13G
- Filer
- Eloxx Pharmaceuticals, Inc.
- CIK
- CIK 1035354
- Filed
- Dec 29, 2017
- Reporting period
- Dec 19, 2017
- Description
- Schedule 13G beneficial ownership